Integrated Health Maintenance Reminders for Improved HPV Vaccine Administration: Toward Improvements in Completion Disparities.


Journal

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176

Informations de publication

Date de publication:
Jul 2023
Historique:
revised: 23 11 2022
received: 29 08 2022
accepted: 11 12 2022
pmc-release: 01 07 2024
medline: 26 6 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: ppublish

Résumé

To evaluate the effect of a health maintenance reminder (HMR) on human papillomavirus (HPV) vaccine administration and completion across different age, insurance, and race cohorts. Retrospective pre-post analysis. Academic primary care. Patients aged 9 to 26 who had initiated the HPV vaccine series from 2016 to 2021 were analyzed, based on current age-based standards. The cohort was divided based on vaccine uptake before and after the implementation of the HMR program in February 2020. The multivariate analysis estimated the odds of vaccine completion based on sociodemographic factors, and variable interactions were investigated to determine independent associations between sociodemographic factors and HMR implementation. There were 7654 individual patients (mean age was 15.8 years; 46.7 were males; and 50.7% were white). HPV vaccine completion rates increased post-HMR implementation by 59.2% (37% pre-, and 58.9% post-HMR; p < .001) in the entire cohort. Overall, black patients (adjusted odds ratio [aOR] = 0.68; 95% confidence interval [CI]: 0.60, 0.70) and patients ≥18 years (aOR = 0.13; 95% CI: 0.11, 0.15) were significantly less likely to complete their vaccine series; however, this improved significantly following HMR in these groups (p < .001). Post-HMR, race, and insurance status were not independently associated with disparate vaccine completion rates, however, age was, and patients ≤14 or younger had higher odds of vaccine completion (aOR = 3.54; 95% CI: 2.91, 4.32). The implementation of an HMR was associated with increased HPV vaccine uptake across age and race groups in this single-institution study. Future research should explore barriers to implementing HMRs in different health care settings.

Identifiants

pubmed: 36939623
doi: 10.1002/ohn.242
pmc: PMC10293109
mid: NIHMS1864775
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-85

Subventions

Organisme : NIDCR NIH HHS
ID : K01 DE030916
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE032216
Pays : United States

Informations de copyright

© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation.

Références

Lancet Infect Dis. 2010 Dec;10(12):845-52
pubmed: 21051295
Hum Vaccin Immunother. 2019;15(7-8):1929-1934
pubmed: 30252604
Clin Pediatr (Phila). 2011 Dec;50(12):1116-24
pubmed: 21856964
Hum Vaccin Immunother. 2017 Nov 2;13(11):2713-2722
pubmed: 28853980
Am J Public Health. 2018 Jul;108(7):946-950
pubmed: 29771616
Hum Vaccin Immunother. 2013 Jul;9(7):1413-20
pubmed: 23571170
Pediatrics. 2013 Jun;131(6):1114-24
pubmed: 23650297
SSM Popul Health. 2022 Mar 26;18:101082
pubmed: 35493405
Acad Pediatr. 2020 Apr;20(3):364-373
pubmed: 31108236
MMWR Morb Mortal Wkly Rep. 2021 Sep 03;70(35):1183-1190
pubmed: 34473682
Prev Med Rep. 2020 Aug 28;20:101194
pubmed: 32963935
Hum Vaccin Immunother. 2018;14(8):2016-2024
pubmed: 29708826
Am J Transplant. 2020 Jul;20(7):1930-1931
pubmed: 32596921
Am J Manag Care. 2017 Nov 1;23(11):e353-e359
pubmed: 29182355
Hum Vaccin Immunother. 2019;15(1):146-155
pubmed: 30148974
Pediatrics. 2007 Oct;120(4):707-14
pubmed: 17908756
J Adolesc Health. 2010 Dec;47(6):596-9
pubmed: 21094437
Vaccine. 2011 Mar 21;29(14):2548-54
pubmed: 21300098
Pediatrics. 2011 Jan;127(1):77-84
pubmed: 21149425
J Clin Oncol. 2011 Nov 10;29(32):4294-301
pubmed: 21969503
JAMA Otolaryngol Head Neck Surg. 2020 Dec 1;146(12):1099-1101
pubmed: 33151285
J Adolesc Health. 2019 Jan;64(1):107-115
pubmed: 30314866
JAMA Otolaryngol Head Neck Surg. 2013 Oct;139(10):1037-42
pubmed: 23989246
F1000Res. 2017 Jun 12;6:866
pubmed: 28663791
J Community Health. 2018 Aug;43(4):756-760
pubmed: 29453619
MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):840-845
pubmed: 34111058
JAMA. 2013 May 1;309(17):1793-802
pubmed: 23632723
Pediatrics. 2007 May;119(5):e1033-9
pubmed: 17473076
Prev Med Rep. 2020 Jul 11;19:101163
pubmed: 32714778
J Am Board Fam Med. 2015 May-Jun;28(3):324-33
pubmed: 25957365
Vaccine. 2011 Jan 10;29(3):528-34
pubmed: 21050904
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702
pubmed: 31415491
Vaccine. 2011 May 12;29(21):3767-72
pubmed: 21440038
Hum Vaccin Immunother. 2021 Dec 2;17(12):5390-5396
pubmed: 34736353
Cleve Clin J Med. 2019 Mar;86(3):173-178
pubmed: 30849035
MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):724-728
pubmed: 31437140
Hum Vaccin Immunother. 2014;10(8):2163-7
pubmed: 25424919

Auteurs

Jess D Rames (JD)

Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA.
Duke University Pratt School of Engineering, Durham, North Carolina, USA.
Department of Plastic and Reconstructive Surgery, Mayo Clinic, Rochester, Minnesota, USA.

Nicholas A Frisco (NA)

Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA.

Rong Jiang (R)

Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University, Durham, North Carolina, USA.

Kevin P Shah (KP)

Department of Medicine, Duke Primary Care, Durham, North Carolina, USA.

Russel R Kahmke (RR)

Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA.
Duke Cancer Institute, Durham, North Carolina, USA.

Liana Puscas (L)

Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA.

Nosayaba Osazuwa-Peters (N)

Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA.
Duke Cancer Institute, Durham, North Carolina, USA.
Duke University School of Medicine, Durham, North Carolina, USA.
Duke Department of Population Health Sciences, Durham, North Carolina, USA.

Daniel J Rocke (DJ)

Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA.
Duke Cancer Institute, Durham, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH